These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21237484)

  • 21. Toll-like receptor 9 is a novel biomarker for esophageal squamous cell dysplasia and squamous cell carcinoma progression.
    Takala H; Kauppila JH; Soini Y; Selander KS; Vuopala KS; Lehenkari PP; Saarnio J; Karttunen TJ
    J Innate Immun; 2011; 3(6):631-8. PubMed ID: 21876325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. P16 and Ki67 immunostaining is a useful adjunct in the assessment of biopsies for HPV-associated anal intraepithelial neoplasia.
    Walts AE; Lechago J; Bose S
    Am J Surg Pathol; 2006 Jul; 30(7):795-801. PubMed ID: 16819320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer-associated expression of minichromosome maintenance 3 gene in several human cancers and its involvement in tumorigenesis.
    Ha SA; Shin SM; Namkoong H; Lee H; Cho GW; Hur SY; Kim TE; Kim JW
    Clin Cancer Res; 2004 Dec; 10(24):8386-95. PubMed ID: 15623617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minichromosome maintenance protein 7 in colorectal cancer: implication of prognostic significance.
    Nishihara K; Shomori K; Fujioka S; Tokuyasu N; Inaba A; Osaki M; Ogawa T; Ito H
    Int J Oncol; 2008 Aug; 33(2):245-51. PubMed ID: 18636144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minichromosome maintenance-7 and geminin are reliable prognostic markers in patients with oral squamous cell carcinoma: immunohistochemical study.
    Tamura T; Shomori K; Haruki T; Nosaka K; Hamamoto Y; Shiomi T; Ryoke K; Ito H
    J Oral Pathol Med; 2010 Apr; 39(4):328-34. PubMed ID: 20136698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of minichromosome maintenance 2 (MCM2), Ki-67, and cell-cycle-related molecules, and apoptosis in the normal-dysplasia-carcinoma sequence of the oral mucosa.
    Kodani I; Shomori K; Osaki M; Kuratate I; Ryoke K; Ito H
    Pathobiology; 2001; 69(3):150-8. PubMed ID: 11872961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apoptosis and cell proliferation in esophageal precancerous and cancerous lesions: study of a high-risk population in northern China.
    Wang LD; Zhou Q; Yang WC; Yang CS
    Anticancer Res; 1999; 19(1A):369-74. PubMed ID: 10226569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expression of nucleostemin mRNA and protein in the esophageal squamous cell carcinoma].
    Zhang GY; Yin L; Li SL; Xing WY; Zhao QM; Le XP; Gao DL; Chen KS; Zhang YH; Zhang QX
    Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):125-8. PubMed ID: 18646696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biologic characteristics of esophageal epithelial dysplasia assessed by proliferating cell nuclear antigen.
    Koga Y; Kuwano H; Sugimachi K
    Cancer; 1996 Jan; 77(2):237-44. PubMed ID: 8625229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus.
    Koide N; Nishio A; Sato T; Sugiyama A; Miyagawa S
    Am J Gastroenterol; 2004 Sep; 99(9):1667-74. PubMed ID: 15330899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytopathology of the esophagus. An overview of esophageal cytopathology in China.
    Shu YJ
    Acta Cytol; 1983; 27(1):7-16. PubMed ID: 6573834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of p21WAF1 predicts outcome of esophageal cancer patients treated by surgery alone or by combined therapy modalities.
    Sarbia M; Stahl M; zur Hausen A; Zimmermann K; Wang L; Fink U; Heep H; Dutkowski P; Willers R; Müller W; Seeber S; Gabbert HE
    Clin Cancer Res; 1998 Nov; 4(11):2615-23. PubMed ID: 9829724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of immunoglobulin G in esophageal squamous cell carcinomas and its association with tumor grade and Ki67.
    Zhang L; Hu S; Korteweg C; Chen Z; Qiu Y; Su M; Gu J
    Hum Pathol; 2012 Mar; 43(3):423-34. PubMed ID: 21855109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility.
    Rodins K; Cheale M; Coleman N; Fox SB
    Clin Cancer Res; 2002 Apr; 8(4):1075-81. PubMed ID: 11948116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between proliferation markers: PCNA, Ki-67, MCM-2 and antiapoptotic protein Bcl-2 in colorectal cancer.
    Guzińska-Ustymowicz K; Pryczynicz A; Kemona A; Czyzewska J
    Anticancer Res; 2009 Aug; 29(8):3049-52. PubMed ID: 19661314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Precancerous lesions and biologic markers in esophageal cancer.
    Mufti SI; Zirvi KA; Garewal HS
    Cancer Detect Prev; 1991; 15(4):291-301. PubMed ID: 1794136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coexpression of vascular endothelial growth factor and p53 protein in squamous cell carcinoma of the esophagus.
    Koide N; Nishio A; Hiraguri M; Hanazaki K; Adachi W; Amano J
    Am J Gastroenterol; 2001 Jun; 96(6):1733-40. PubMed ID: 11419822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minichromosome maintenance protein 2 is a reliable proliferative marker in breast carcinoma.
    Reena RM; Mastura M; Siti-Aishah MA; Munirah MA; Norlia A; Naqiyah I; Rohaizak M; Sharifah NA
    Ann Diagn Pathol; 2008 Oct; 12(5):340-3. PubMed ID: 18774496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.